Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion type Assertion NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_head.
- NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion description "[HER2 gene amplification and HER2 protein overexpression are important factors in predicting clinical sensitivity to anti-HER2 monoclonal antibody therapy in breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_provenance.
- NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion evidence source_evidence_literature NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_provenance.
- NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion SIO_000772 21046136 NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_provenance.
- NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion wasDerivedFrom befree-2016 NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_provenance.
- NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_assertion wasGeneratedBy ECO_0000203 NP850157.RAsZ3TbGEfnY57-n_afZ0_ciRUqlRPdrVFAlNaFmoXqOw130_provenance.